LHR
Lunate Holding RSC Portfolio holdings
AUM
$211M
1 Year Est. Return
–
AUM
$211M
AUM Growth
–
Holding
4
Top Buys
| 1 | +$96.1M | |
| 2 | +$57.2M | |
| 3 | +$35.1M | |
| 4 |
Neumora Therapeutics
NMRA
|
+$22.5M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 56.21% |
| 2 | Consumer Discretionary | 27.13% |
| 3 | Real Estate | 16.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$10.7B
| $96.1M | 45.54% |
+2,196,200
|
|
||
2
Birkenstock
BIRK
$7.21B
| $57.2M | 27.13% |
+1,010,000
|
|
||
|
LINE
3
Lineage Inc
LINE
$8.87B
| $35.1M | 16.66% |
+600,000
|
|
||
|
4
Neumora Therapeutics
NMRA
$478M
| $22.5M | 10.67% |
+2,124,143
|
|